Bosh sahifa4506 • TYO
add
Sumitomo Pharma Co Ltd
Yopilish kursi
2 933,00 ¥
Kunlik diapazon
2 512,00 ¥ - 3 133,00 ¥
Yillik diapazon
500,00 ¥ - 3 288,00 ¥
Bozor kapitalizatsiyasi
1,17 trln JPY
Oʻrtacha hajm
10,70 mln
Narx/foyda
9,23
Dividend daromadliligi
-
Asosiy maydon
TYO
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 120,62 mlrd | 7,28% |
Joriy xarajat | 52,19 mlrd | 5,24% |
Sof foyda | 8,82 mlrd | -83,50% |
Sof foyda marjasi | 7,31 | -84,62% |
Har bir ulushga tushum | — | — |
EBITDA | 18,32 mlrd | -33,33% |
Amaldagi soliq stavkasi | -0,92% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 57,32 mlrd | -32,87% |
Jami aktivlari | 815,52 mlrd | -4,29% |
Jami passivlari | 526,58 mlrd | -23,24% |
Umumiy kapital | 288,94 mlrd | — |
Tarqatilgan aksiyalar | 397,29 mln | — |
Narxi/balansdagi bahosi | 4,03 | — |
Aktivlardan daromad | 4,08% | — |
Kapitaldan daromad | 6,04% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,82 mlrd | -83,50% |
Operatsiyalardan naqd pul | 24,24 mlrd | 2 481,79% |
Sarmoyadan naqd pul | -3,26 mlrd | -40 662,50% |
Moliyadan naqd pul | -4,70 mlrd | 70,39% |
Naqd pulning sof oʻzgarishi | 18,83 mlrd | 237,58% |
Boʻsh pul | 19,16 mlrd | 496,88% |
Haqida
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
Tashkil etilgan
14-may, 1897
Bosh ofis
Xodimlar soni
3 832
